1.
Dhillon R, Park L, Gabros S, Nguyen T, Skopit S. Rituximab for linear immunoglobulin A bullous dermatosis. Dermatol Reports [Internet]. 2022 Dec. 29 [cited 2024 Nov. 21];15(2). Available from: https://www.pagepress.org/journals/dr/article/view/9574